CTTN and acute respiratory distress syndrome: However, despite these limitations, our studies of CTTN promoter activity in ECs by the ARDS inflammatory stimuli and by ARDS transcription factors further confirm CTTN and its coding protein, cortactin, as attractive therapeutic targets to significantly attenuate inflammation-induced vascular permeability and inflammatory lung injury during ARDS and VILI [11–13,16,87,88].